Center-Authored Papers

Filters: Author is Gajjar, Amar  [Clear All Filters]
Journal Article
Armstrong GT, Whitton JA, Gajjar A, Kun LE, Chow EJ, Stovall M, Leisenring WM, Robison LL, Sklar CA.  2009.  Abnormal timing of menarche in survivors of central nervous system tumors: A report from the Childhood Cancer Survivor Study.. Cancer. 115(11):2562-70. Abstract
Pajtler KW, Mack SC, Ramaswamy V, Smith CA, Witt H, Smith A, Hansford JR, von Hoff K, Wright KD, Hwang E et al..  2016.  The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.. Acta neuropathologica. Abstract
Shih DJH, Northcott PA, Remke M, Korshunov A, Ramaswamy V, Kool M, Luu B, Yao Y, Wang X, Dubuc AM et al..  2014.  Cytogenetic Prognostication Within Medulloblastoma Subgroups.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(9):886-96. Abstract
Cho Y-J, Tsherniak A, Tamayo P, Santagata S, Ligon A, Greulich H, Berhoukim R, Amani V, Goumnerova L, Eberhart CG et al..  2011.  Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(11):1424-30. Abstract
Gottardo NG, Hansford JR, McGlade JP, Alvaro F, Ashley DM, Bailey S, Baker DL, Bourdeaut F, Cho Y-J, Clay M et al..  2014.  Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.. Acta neuropathologica. 127(2):189-201. Abstract
Gajjar A, Bowers DC, Karajannis MA, Leary S, Witt H, Gottardo NG.  2015.  Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(27):2986-2998. Abstract
Morfouace M, Shelat A, Jacus M, Freeman BB, Turner D, Robinson S, Zindy F, Wang Y-D, Finkelstein D, Ayrault O et al..  2014.  Pemetrexed and Gemcitabine as Combination Therapy for the Treatment of Group3 Medulloblastoma.. Cancer cell. 25(4):516-29. Abstract
Hatton BA, Ellison DW, Gajjar A, Kool M, Fero M, Olson JM.  2013.  Prognostic value and functional consequences of cell cycle inhibitor p27Kip1 loss in medulloblastoma.. Biomarker research. 1(1):14. Abstract
Ramaswamy V, Hielscher T, Mack SC, Lassaletta A, Lin T, Pajtler KW, Jones DTW, Luu B, Cavalli FMG, Aldape K et al..  2016.  Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(21):2468-77. Abstract